Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Participant perceptions of a novel physiotherapy approach ("Blue Prescription") for increasing levels of physical activity in people with multiple sclerosis: a qualitative study following intervention.
The Evi5 family in cellular physiology and pathology.
An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.
[STUDY ON RELATIONSHIP BETWEEN DIFFUSION TENSOR IMAGING AND VISUAL EVOKED POTENTIAL IN VISUAL PATHWAY OF NEUROMYELITIS OPTICA].
The protein arginine deiminases: Structure, function, inhibition, and disease.
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.
Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
USPIO-Enhanced MRI Neuroimaging: A Review.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Chemokine receptor expression by inflammatory T cells in EAE.
Development and Validation of a New Self-Report Measure of Pain Behaviors.
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Helicobacter pylori and autoimmune disease: Cause or bystander.
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
Pages
« first
‹ previous
…
508
509
510
511
512
513
514
515
516
…
next ›
last »